Our findings also implicate APOE4 as a possible contributor to lysosomal dysfunction in neurons, and provide a rationale for expanding therapeutic trials targeting the lysosomal system to late-onset Alzheimer disease. The gene discussed is APOE; the disease is Alzheimer disease.